Log in to save to my catalogue

Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis

Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9820515

Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis

About this item

Full title

Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis

Publisher

Switzerland: MDPI

Journal title

International journal of molecular sciences, 2022-12, Vol.24 (1), p.239

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI

More information

Scope and Contents

Contents

Fibrosing diseases are a major medical problem, and are associated with more deaths per year than cancer in the US. Sialidases are enzymes that remove the sugar sialic acid from glycoconjugates. In this review, we describe efforts to inhibit fibrosis by inhibiting sialidases, and describe the following rationale for considering sialidases to be a p...

Alternative Titles

Full title

Inhibitors of the Sialidase NEU3 as Potential Therapeutics for Fibrosis

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9820515

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9820515

Other Identifiers

ISSN

1422-0067

E-ISSN

1422-0067

DOI

10.3390/ijms24010239

How to access this item